Is CMXC or XYLD a better dividend investment in 2026?

CMXC currently yields 470.59% with a 5% 5-year dividend growth rate. XYLD yields 10.98% with 0.5% growth. The better choice depends on your goal: CMXC offers higher current income.

What is the dividend yield difference between CMXC and XYLD?

CMXC has a forward dividend yield of 470.59% ($2.00/share annually). XYLD yields 10.98% ($4.30/share annually). The yield gap is 459.61 percentage points.

Home › Compare › CMXC vs XYLD

CMXC vs XYLD: Dividend Comparison 2026

CMXC yields 470.59% · XYLD yields 10.98%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 CMXC wins by $38545.09M in total portfolio value

INVESTMENT

TIME HORIZON10 years

CMXC

● Live price

470.59%

Share price

$0.43

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$38545.12M

Annual income

$27,182,357,871.92

Full CMXC calculator →

XYLD

Global X S&P 500 Covered Call ETF

● Live price

10.98%

Share price

$39.13

Annual div

$4.30

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$25.3K

Annual income

$3,219.02

Full XYLD calculator →

Portfolio growth — CMXC vs XYLD

📍 CMXC pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	CMXC	XYLD
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, CMXC + XYLD cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

CMXC pays

XYLD pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CMXC

Annual income on $10K today (after 15% tax)

$40,000.00/yr

After 10yr DRIP, annual income (after tax)

$23,105,004,191.13/yr

XYLD

Annual income on $10K today (after 15% tax)

$933.63/yr

After 10yr DRIP, annual income (after tax)

$2,736.17/yr

At 15% tax rate, CMXC beats the other by $23,105,001,454.96/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CMXC + XYLD for your $10,000?

CMXC: 50%XYLD: 50%

100% XYLD50/50100% CMXC

Portfolio after 10yr

$19272.57M

Annual income

$13,591,180,545.47/yr

Blended yield

70.52%

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CMXC buys

XYLD buys

No recent congressional trades found for CMXC or XYLD in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricCMXCXYLD

Forward yield	470.59% ✓	10.98%
Annual dividend / share	$2.00	$4.30 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	0%
Portfolio after 10y	$38545.12M ✓	$25.3K
Annual income after 10y	$27,182,357,871.92 ✓	$3,219.02
Total dividends collected	$37542.88M ✓	$19.6K
Payment frequency	quarterly	monthly
Sector	Stock	ETF

Year-by-year: CMXC vs XYLD ($10,000, DRIP)

Year	CMXC Portfolio	CMXC Income/yr	XYLD Portfolio	XYLD Income/yr	Gap
1← crossover	$57,759	$47,058.82	$10,818	$1,098.39	+$46.9K → CMXC
2	$315,826	$254,024.51	$11,738	$1,222.51	+$304.1K → CMXC
3	$1,636,076	$1,298,141.44	$12,774	$1,364.64	+$1.62M → CMXC
4	$8,035,425	$6,284,824.27	$13,944	$1,527.86	+$8.02M → CMXC
5	$37,445,846	$28,847,941.19	$15,270	$1,715.87	+$37.43M → CMXC
6	$165,706,448	$125,639,392.36	$16,775	$1,933.09	+$165.69M → CMXC
7	$696,916,266	$519,610,366.98	$18,490	$2,184.87	+$696.90M → CMXC
8	$2,788,074,169	$2,042,373,764.24	$20,450	$2,477.63	+$2788.05M → CMXC
9	$10,619,401,952	$7,636,162,591.12	$22,697	$2,819.19	+$10619.38M → CMXC
10	$38,545,117,961	$27,182,357,871.92	$25,280	$3,219.02	+$38545.09M → CMXC

CMXC vs XYLD: Complete Analysis 2026

CMXC — Stock

Cell MedX Corp., a biotech company, focuses on the discovery, development, and commercialization of therapeutic and non-therapeutic products for patients with diabetes, Parkinson's disease, high blood pressure, neuropathy, and kidney functions. It develops and manufactures eBalance Pro System for professional use by healthcare practitioners in a clinical setting; and eBalance Home System for home use for general wellness and pain management treatment, which are controlled by the eBalance Console that acts as the central controller for three pre-programmed microcurrent algorithms, including wellness, pain management, and dual. The company was formerly known as Sports Asylum, Inc. and changed its name to Cell MedX Corp. in September 2014. Cell MedX Corp. was incorporated in 2010 and is based in Carson City, Nevada.

Full CMXC Calculator →

XYLD — ETF

The Global X S&P 500 Covered Call ETF (XYLD) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Cboe S&P 500 BuyWrite Index.

Full XYLD Calculator →

📬

Get this CMXC vs XYLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CMXC vs SCHD CMXC vs JEPI CMXC vs O CMXC vs KO CMXC vs MAIN CMXC vs QYLD CMXC vs JEPQ CMXC vs RYLD

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.